Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Equity Ratio (2022 - 2025)

Envoy Medical's Equity Ratio history spans 4 years, with the latest figure at 1.42 for Q4 2025.

  • Quarterly results put Equity Ratio at 1.42 for Q4 2025, up 13.01% from a year ago — trailing twelve months through Dec 2025 was 1.42 (up 13.01% YoY), and the annual figure for FY2025 was 1.42, up 13.01%.
  • Equity Ratio for Q4 2025 was 1.42 at Envoy Medical, down from 0.94 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.23 in Q3 2023 to a low of 14.16 in Q4 2022.
  • The 4-year median for Equity Ratio is 1.02 (2023), against an average of 1.9.
  • Peak annual rise in Equity Ratio hit 477.81% in 2023, while the deepest fall reached 1623.26% in 2023.
  • Year by year, Equity Ratio stood at 14.16 in 2022, then surged by 98.48% to 0.21 in 2023, then crashed by 660.52% to 1.63 in 2024, then increased by 13.01% to 1.42 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 1.42, 0.94, and 3.02 for Q4 2025, Q3 2025, and Q2 2025 respectively.